Insider Trading29 Sept 2026, 11:11 am
Piramal Pharma Ltd: Trading Window Closure for Insider Trading
AI Summary
Piramal Pharma Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the half-year ending September 30, 2026. The exact date of the board meeting to approve these results will be communicated later.
Key Highlights
- Trading window closed for designated persons and relatives.
- Closure effective from October 1, 2026.
- Period extends until 48 hours post H1 FY27 results declaration.
- Adherence to SEBI Insider Trading Regulations.
- Board meeting date for results approval to be announced.
Price Impact
More from PPLPHARMA